1. A 2-year prospective multicenter study of ultrasound cyclo plasty for glaucoma
- Author
-
Alessandro Bagnis, Carlo Enrico Traverso, Chiara Del Noce, Aldo Vagge, Marco Pellegrini, Adriano Carnevali, Giuseppe Giannaccare, Federico Bernabei, Lorenzo Ferro Desideri, Francesco Biagini, Lara Enrica Urbini, Vincenzo Scorcia, Fulvio Bergamini, and Paola Cassottana
- Subjects
Male ,medicine.medical_specialty ,genetic structures ,Science ,medicine.medical_treatment ,Ocular hypertension ,Glaucoma ,Article ,NO ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Ciliary body ,80 and over ,medicine ,Glaucoma surgery ,Humans ,Multicenter Studies as Topic ,Prospective Studies ,Prospective cohort study ,Aged ,Aged, 80 and over ,Multidisciplinary ,business.industry ,Ultrasound ,Middle Aged ,medicine.disease ,eye diseases ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,Outcomes research ,030221 ophthalmology & optometry ,Medicine ,High-Intensity Focused Ultrasound Ablation ,Female ,Follow-Up Studies ,sense organs ,Acetazolamide ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Ultrasound cyclo plasty (UCP) is a recently developed surgical technique for glaucoma allowing a selective and controlled coagulation of the ciliary body. We herein investigated the long-term efficacy and safety of UCP for the treatment of glaucoma. This prospective study included patients with primary and secondary glaucoma. All surgeries were performed using the EyeOP1 device (Eye Tech Care, Rillieux-la-Pape, France). Sixty-six patients were included, and 60 completed regularly the 2-year follow-up. Preoperative IOP was 28.5 ± 9.6 mmHg and significantly decreased to 17.0 ± 5.4 at 2 years (p p
- Published
- 2021
- Full Text
- View/download PDF